title: Levomepromazine-induced lupus?
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Fletcher
mesh_terms: D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000473:pathology / Q000628:therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000473:pathology / Q000628:therapy; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000473:pathology; D008728:Methotrimeprazine / Q000009:adverse effects* / Q000627:therapeutic use; D010166:Palliative Care
chemical_list: D018712:Analgesics, Non-Narcotic; D014150:Antipsychotic Agents; D008728:Methotrimeprazine